You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 6, June 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Postirradiation Sarcoma in Retinoblastoma

Induction or Predisposition?

Matthew B. Schwarz, MD; Lawrence P. A. Burgess, MD, MAS, MC; Willard E. Fee, Jr, MD; Sarah S. Donaldson, MD

Arch Otolaryngol Head Neck Surg. 1988;114(6):640-644.


Abstract

• An alarmingly high rate of postirradiation sarcomas following treatment for retinoblastoma has been described in the literature. We present four new cases and report 57 others from the English literature. Osteogenic sarcoma was the predominant histologic type (58%), followed by fibrosarcoma (21%) and various other sarcomas (21%). The average latency period between irradiation and development of the second primary (sarcoma) was 12.4 years. Irrespective of irradiation, a genetic linkage between retinoblastoma and osteogenic sarcoma on the 13q14 chromosome is recognized. Through a pleiotropic effect of this same chromosome, a predisposition for other sarcomas may exist as well. Finally, a strong role for radiation induction is proposed for all of these postirradiation sarcomas. This is based on the increased number of sarcomas arising in the field of prior irradiation (sites uncharacteristic of spontaneously occurring primary sarcomas) and the prolonged latency periods.

(Arch Otolaryngol Head Neck Surg 1988;114:640-644)



Author Affiliations

From the Division of Otolaryngology, Departments of Surgery (Drs Schwarz, Burgess, and Fee) and Therapeutic Radiation (Dr Donaldson), Stanford (Calif) University Medical Center.


Footnotes

Accepted for publication Jan 11, 1988.

Read in part before the 28th annual meeting of the American Society for Head and Neck Surgery, Palm Beach, Fla, May 8, 1986.

The opinions or assertions contained herein are the private views of the authors and should not be considered as official or as reflecting the views of the Department of the Army or Department of Defense.

Reprint requests to Division of Otolaryngology/Head and Neck Surgery, Stanford University Medical Center, Edwards Bldg, Room 135, Stanford, CA 94305 (Dr Fee).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

CT and MRI Features of Recurrent Tumors and Second Primary Neoplasms in Pediatric Patients with Retinoblastoma
Tateishi et al.
Am. J. Roentgenol. 2003;181:879-884.
ABSTRACT | FULL TEXT  

Soft tissue, pelvic, and urinary bladder leiomyosarcoma as second neoplasm following hereditary retinoblastoma
Venkatraman et al.
J. Clin. Pathol. 2003;56:233-236.
ABSTRACT | FULL TEXT  

Combined Modality Treatment for Osteosarcoma Occurring as a Second Malignant Disease
Bielack et al.
JCO 1999;17:1164-1164.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.